Clinical Trial Update: LYR-210 Depot (LYR-210) for Adult Subjects With Chronic Sinusitis (LANTERN Study) [Phase 2]

View source ↗

Summary

Phase 2 trial update for LYR-210 depot in adults with chronic sinusitis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhinosinusitis
• Sinusitis

Drugs mentioned

• LYR-210

Snippet

Sponsor: Lyra Therapeutics | Conditions: Chronic Sinusitis, Chronic Rhinosinusitis (Diagnosis) | Phase 2 | Status: COMPLETED | Results posted: 2023-06-06